Improved survival for incurable mind tumor, offering ‘a crack within the armor’

Researchers have discovered a possible drug candidate that improved outcomes for sufferers with a sort of childhood mind tumor for which there aren’t any efficient therapies. The compound, referred to as ONC201, practically doubled survival for sufferers with diffuse midline glioma (DMG) or diffuse intrinsic pontine glioma (DIPG), in comparison with earlier sufferers.